You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Scott's Miracle-Gro expects fiscal 27 net sales growth of 2% to 4% and adjusted EPS of $4.70 to $4.90 per share, with approximately $275 million free cash flow and continued gross margin expansion.
The Scotts Miracle-Gro Company reported fiscal 2026 net sales of $3.29 billion, up 1%, and non-GAAP adjusted EPS of $4.48, up 18% and above guidance. Fiscal 2027 guidance calls for 2% to 4% sales growth and $4.70 to $4.90 adjusted EPS.
On October 13, 2026, Scotts Miracle-Gro's subsidiary The Scotts Company LLC entered into a Separation Agreement with former EVP & Chief Strategy Officer Christopher J. Hagedorn, whose termination date was September 30, 2026, providing 24 months of severance pay and 2.0x Target Bonus.
The Scotts Miracle-Gro Company reported that Adam Hanft resigned from its Board effective immediately on September 8, 2026; his consulting relationship with Hanft Ideas LLC will continue.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. SMG reaffirmed fiscal 2026 guidance and raised its full-year non-GAAP adjusted EPS from continuing operations outlook to $4.30–$4.45 (from $4.15–$4.35), while warning Q4 U.S. consumer sales will likely land at the low end of guidance due to elevated retailer inventories and noting Q3 GAAP results were pressured by ~$64M of impairment/restructuring/severance items.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Share-based compensation | $10.2M | Three months ended June 27, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMG
this stock
Scotts Miracle-Gro Co
|
$3.72B | +9.4% | +6.2% | 53.2 | 8.9% |
|
NTR
Nutrien Ltd.
|
$33.78B | +15.4% | — | — | 1.8% |
|
CF
CF Industries Holdings, Inc.
|
$18.30B | +61.7% | +19.3% | 8.9 | 6.1% |
|
YARIY
Yara International ASA
|
$10.87B | +4.7% | — | — | 0.0% |
|
MOS
Mosaic Co
|
$6.97B | -9.0% | +8.4% | — | 11.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
The Scotts Miracle-Gro Company reported fiscal 2026 net sales of $3.29 billion, up 1%, and non-GAAP adjusted EPS of $4.48, up 18% and above guidance. Fiscal 2027 guidance calls for 2% to 4% sales growth and $4.70 to $4.90 adjusted EPS.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMG | -1.3% | +17.0% | +8.4% | +2.6% | +9.4% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -3.9% | +18.2% | +7.9% | +2.8% | -1.2% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
